Household Transmission and Genomic Diversity of Respiratory Syncytial Virus (RSV) in the United States, 2022-2023

被引:0
|
作者
Cox, Sarah N. [1 ,2 ]
Roychoudhury, Pavitra [3 ,4 ]
Frivold, Collrane [1 ,2 ]
Acker, Zack [5 ]
Babu, Tara M. [1 ]
Boisvert, Cassandra L. [6 ]
Carone, Marco [7 ]
Ehmen, Brenna [5 ]
Englund, Janet A. [8 ,9 ]
Feldstein, Leora R. [10 ]
Gamboa, Luis [5 ]
Grindstaff, Sally [5 ]
Grioni, Hanna M. [8 ]
Han, Peter D. [5 ]
Hoffman, Katherine L.
Kim, Hyeong Geon
Kuntz, Jennifer L. [6 ]
Lo, Natalie K. [1 ]
Lockwood, Christina M. [5 ]
Mccaffrey, Kathryn [5 ]
Mularski, Richard A. [6 ]
Hatchie, Tara L. [1 ]
Reich, Sacha L. [6 ]
Schmidt, Mark A. [6 ]
Smith, Ning [6 ]
Starita, Lea M. [5 ,11 ]
Varga, Alexandra [6 ]
Yetz, Neil [6 ]
Naleway, Allison L. [6 ]
Weil, Ana A. [1 ]
Chu, Helen Y. [1 ]
机构
[1] Univ Washington, Dept Med, 750 Republican St, Seattle, WA 98109 USA
[2] Univ Washington, Dept Epidemiol, 750 Republican St, Seattle, WA 98109 USA
[3] Univ Washington, Dept Lab Med & Pathol, Seattle, WA USA
[4] Fred Hutchinson Canc Ctr, Vaccine & Infect Dis Div, Seattle, WA USA
[5] Brotman Baty Inst Precis Med, Seattle, WA USA
[6] Kaiser Permanente Ctr Hlth Res, Portland, OR USA
[7] Univ Washington, Dept Biostat, Seattle, WA USA
[8] Seattle Childrens Res Inst, Seattle, WA USA
[9] Univ Washington, Dept Pediat, Seattle, WA USA
[10] CDCP, Natl Ctr Immunizat & Resp Dis, Coronavirus & Other Resp Viruses Div, Atlanta, GA USA
[11] Univ Washington, Dept Genome Sci, Seattle, WA USA
关键词
respiratory syncytial virus; household transmission; secondary attack rate; genomics; community surveillance; INFECTION; INFANTS;
D O I
10.1093/cid/ciaf048
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background Household transmission of respiratory viruses may drive community spread. Few recent studies have examined household respiratory syncytial virus (RSV) transmission in the United States. Methods We conducted a prospective community-based cohort study from 1 June 2022 to 31 May 2023. Participants had blood samples collected and completed nasal swabs and surveys at least weekly, irrespective of symptoms. We tested serum for RSV antibody, nasal swabs by quantitative reverse transcription polymerase chain reaction (RT-qPCR), and performed whole genome sequencing. We evaluated secondary RSV transmission and associated risk factors based on a log-linear Poisson regression model. Results RSV was detected among 310 (10%) participants within 200 (20%) households. Most (94%) index cases were symptomatic. We identified 37 cases of potential secondary transmission within 14 days of a distinct index case (10%, 95% confidence interval [CI]: 7%, 14%); median age of index and secondary cases were 6 (interquartile range [IQR]: 3-10) and 35 (7-41) years, respectively, with 89% (24/27) of index cases aged 6 months to 12 years. Factors associated with increased risk of RSV transmission included index case viral detection >= 1 week and contact age <= 12 years. Of 120 sequenced specimens, the main lineages represented were A.d.5.2 (n = 37) and A.d.1 (n = 30). Sequenced viruses from households with >= 2 RSV infections were similar when occurring within <= 14 days (mean pairwise difference 4 [range 0-13], n = 17 households), compared to those >14 days (137 [37-236], n = 2). Conclusions Most RSV household transmission occurs from infants and young children to adults. Viral genome sequencing demonstrated that multiple household infections within a 14-day period are likely due to within-household transmission.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Modelling the household-level impact of a maternal respiratory syncytial virus (RSV) vaccine in a high-income setting
    Patricia T. Campbell
    Nicholas Geard
    Alexandra B. Hogan
    BMC Medicine, 18
  • [32] Rates of respiratory syncytial virus (RSV)-associated hospitalization among adults with congestive heart failure-United States, 2015-2017
    Kujawski, Stephanie A.
    Whitaker, Michael
    Ritchey, Matthew D.
    Reingold, Arthur L.
    Chai, Shua J.
    Anderson, Evan J.
    Openo, Kyle P.
    Monroe, Maya
    Ryan, Patricia
    Bye, Erica
    Como-Sabetti, Kathryn
    Barney, Grant R.
    Muse, Alison
    Bennett, Nancy M.
    Felsen, Christina B.
    Thomas, Ann
    Crawford, Courtney
    Talbot, H. Keipp
    Schaffner, William
    Gerber, Susan, I
    Langley, Gayle E.
    Kim, Lindsay
    PLOS ONE, 2022, 17 (03):
  • [33] The Effect of Birth Month on the Risk of Respiratory Syncytial Virus Hospitalization in the First Year of Life in the United States
    Lloyd, Patricia Calderon
    May, Larissa
    Hoffman, Daniel
    Riegelman, Richard
    Simonsen, Lone
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2014, 33 (06) : E135 - E140
  • [34] Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus-Associated Lower RespiratoryTract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023
    Fleming-Dutra, Katherine E.
    Jones, Jefferson M.
    Roper, Lauren E.
    Prill, Mila M.
    Ortega-Sanchez, Ismael R.
    Moulia, Danielle L.
    Wallace, Megan
    Godfrey, Monica
    Broder, Karen R.
    Tepper, Naomi K.
    Brooks, Oliver
    Sanchez, Pablo J.
    Kotton, Camille N.
    Mahon, Barbara E.
    Long, Sarah S.
    Mcmorrow, Meredith L.
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2023, 72 (41): : 1115 - 1122
  • [35] Respiratory syncytial virus (RSV) infection among infants in the first year of life (Czech Republic, 2017-2022)
    Pazdiora, P.
    Sanca, O.
    EPIDEMIOLOGIE MIKROBIOLOGIE IMUNOLOGIE, 2024, 73 (02): : 67 - 75
  • [36] Prevalence of Respiratory Syncytial Virus (RSV) Risk Factors and Cost Implications of Immunoprophylaxis to Infants 32 to 35 Weeks Gestation for Health Plans in the United States
    Krilov, Leonard R.
    Palazzi, Debra L.
    Fernandes, Ancilla W.
    Klein, Robert W.
    Mahadevia, Parthiv J.
    VALUE IN HEALTH, 2010, 13 (01) : 77 - 86
  • [37] Vitamin A therapy for children with respiratory syncytial virus infection: A multicenter trial in the United States
    Bresee, JS
    Fischer, M
    Dowell, SF
    Johnston, BD
    Biggs, VM
    Levine, RS
    Lingappa, JR
    Keyserling, HL
    Petersen, KM
    Bak, JR
    Gary, HE
    Sowell, AL
    Rubens, CE
    Anderson, LJ
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1996, 15 (09) : 777 - 782
  • [38] Determining the Seasonality of Respiratory Syncytial Virus in the United States: The Impact of Increased Molecular Testing
    Midgley, Claire M.
    Haynes, Amber K.
    Baumgardner, Jason L.
    Chommanard, Christina
    Demas, Sara W.
    Prill, Mila M.
    Abedi, Glen R.
    Curns, Aaron T.
    Watson, John T.
    Gerber, Susan I.
    JOURNAL OF INFECTIOUS DISEASES, 2017, 216 (03): : 345 - 355
  • [39] Hospitalizations for Respiratory Syncytial Virus Among Adults in the United States, 1997-2012
    Pastula, Susan T.
    Hackett, Judith
    Coalson, Jenna
    Jiang, Xiaohui
    Villafana, Tonya
    Ambrose, Christopher
    Fryzek, Jon
    OPEN FORUM INFECTIOUS DISEASES, 2017, 4 (01):
  • [40] Respiratory Syncytial Virus Surveillance in the United States, 2007-2012 Results from a National Surveillance System
    McGuiness, Catherine Balderston
    Boron, Marnie L.
    Saunders, Brett
    Edelman, Laurel
    Kumar, Veena R.
    Rabon-Stith, Karma M.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2014, 33 (06) : 589 - 594